每经AI快讯，8月27日，东吴证券(601555.SH)公告称，上半年实现营业收入44.28亿元，同比增长 33.63%；归属于母公司股东的净利润19.32亿元，同比增长65.76%。公司拟每10股派发现金红利1.38元 （含税）。 （文章来源：每日经济新闻） ...

证券代码：601555 股票简称：东吴证券 公告编号：2025-037 东吴证券股份有限公司 第四届董事会第三十二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 东吴证券股份有限公司（以下简称"公司"）第四届董事会第三十二次会议 通知于2025年8月15日以电子邮件的方式发出，董事会于2025年8月26日上午在山 东青岛以现场结合线上会议的方式召开，本次会议应出席董事11名，实际出席董 事11名，占董事总数的100%（其中罗妍董事以线上方式参会）。本次会议由董 事长范力先生主持，公司监事、高级管理人员列席会议。会议的召集、召开和表 决程序符合《中华人民共和国公司法》等有关法律、法规、规范性文件和《东吴 证券股份有限公司章程》（以下简称《公司章程》）的有关规定。 二、董事会会议审议情况 会议审议了相关议案并以书面表决方式形成了以下决议： （一）审议通过《关于 2025 年半年度报告及其摘要的议案》 表决结果：11 票同意、0 票反对、0 票弃权。 本议案已经公司董事会审计委员会 2025 ...

东吴证券股份有限公司2025 年半年度报告 公司代码：601555 公司简称：东吴证券 东吴证券股份有限公司 2025 年半年度报告 1 / 178 东吴证券股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人范力、主管会计工作负责人杨伟及会计机构负责人（会计主管人员）李雨妍声 明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配方案或公积金转增股本方案 以公司实施分配方案时股权登记日在册的全体股东所持股份数为基数拟向全体股东每10股派 发现金红利1.38元（含税），以公司现有的股本4,968,702,837股计算，共派发现金红利68,568.10 万元（含税），占2025年半年度合并报表中归属于母公司股东的净利润比例为35.50%。 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的未来计划等前瞻性描述不构成公司对投资者的 ...

格隆汇8月27日｜东吴证券公告，2025年上半年营业收入44.28亿元，同比增长33.63%。净利润19.32亿 元，同比增长65.76%。拟向全体股东每10股派发现金红利1.38元（含税），共派发现金红利6.86亿元 （含税），占2025年半年度合并报表中归属于母公司股东的净利润比例为35.50%。 ...

| | | | 11 Ju | The : Acch | | --- | --- | --- | --- | --- | | 项目 | 本报告期末 | 上年度末 | | 本报告期末比 上年度末增减 | | | | 调整后 | 调整前 | | | | | | | (%) | | 总资产 | 171,869,181,203.19 | 177,804,609,327.34 | 177.804.609.327.34 | -3.34 | | 归属于上市公司 礼体界五米庭 | 42.712.600.494.75 | 41.729.147.936.67 | 41.729.147.936.67 | 2.36 | | 项目 | 本报告期 | 蛋區 出一 | | 本报告期比上 | | | | 调整后 | 调整前 | 年同期增减(%) | | 营业收入 | 4.427.962.991.25 | 3.313.700.948.57 | 5.051.092,585.76 | 33.63 | | 利润总额 | 2.546.117.033.29 | 1.514.354.911.72 | 1.514.354.911.72 | 68.13 | ...

人民财讯8月27日电，东吴证券（601555）8月27日晚间披露半年报，2025年上半年，公司实现营业收入 为44.28亿元，同比增长33.63%；归母净利润19.32亿元，同比增长65.76%；基本每股收益0.39元。公司 拟向全体股东每10股派发现金红利1.38元（含税）。 ...

东吴证券：上半年净利润19.3亿元人民币。 ...

Core Viewpoint - The company has demonstrated strong performance in the first half of 2025, driven by multiple factors including cost reductions in raw materials and expansion in production capacity across various segments [2][5]. Group 1: Performance Analysis - The company's profit growth is attributed to several factors: a decrease in raw material costs in the heat and power generation segment, an increase in sales volume from new projects, and government subsidies received during the reporting period [2]. - The solid waste (hazardous waste) resource utilization segment has seen a reduction in gross margin due to the addition of low-margin production lines, but this has diversified raw material sources and supported overall performance [4]. Group 2: Business Development - The new heat and power generation project at the Pluray Wanzai Industrial Park commenced operations in June 2025, adding 30 MW of installed capacity and a boiler evaporation capacity of 4,420 tons/hour [3]. - The company is focusing on its core business while exploring investment opportunities in the circular economy and is considering international expansion when conditions are favorable [3]. Group 3: Revenue Growth and Market Position - Unlike some competitors in the heat and power generation sector that reported a decline in revenue, the company achieved revenue growth primarily through its solid waste resource utilization business, which added approximately 360 million yuan in revenue due to increased production lines and rising commodity prices [5]. - The company plans to enhance its operational efficiency and production system by optimizing its industrial chain layout and increasing its self-control capabilities in the solid waste resource utilization segment [6].

Core Viewpoint - Minsheng Health's H1 2025 performance met market expectations, with revenue and net profit showing solid growth, driven by core product categories and new product launches [1][2]. Financial Performance - In H1 2025, Minsheng Health achieved revenue of 462 million and net profit of 83 million, representing year-on-year growth of 16.37% and 6.65% respectively [1]. - In Q2 2025, revenue and net profit were 191 million and 20 million, with year-on-year increases of 17.32% and 7.08% [1]. - The core category of vitamins and mineral supplements generated revenue of 426 million, accounting for 92.15% of total revenue, with a year-on-year growth of 9.84% [1]. Profitability and Cost Structure - The gross margin for the vitamin and mineral series decreased by 6.91 percentage points to 54.78% in H1 2025, primarily due to changes in product mix [1]. - Overall gross margin in Q2 2025 was down by 5.09 percentage points to 51.92%, with selling, administrative, and R&D expense ratios showing slight variations [1]. - Net profit margin decreased by 0.88 percentage points to 10.42% [1]. Product Development and Market Position - The company has a strong market position due to its R&D advantages and plans to expand its product matrix in the vitamin and mineral category [2]. - New products, including varenicline tartrate tablets and minoxidil solution, are expected to launch in Q3 2025, which will significantly boost H2 performance [2]. - The acquisition of Zhongke Jiayi has enabled the company to self-supply probiotics, enhancing its product offerings [2]. Earnings Forecast and Investment Rating - The company’s net profit forecasts for 2025-2027 have been adjusted to 107 million, 129 million, and 149 million, reflecting year-on-year growth rates of 16.25%, 20.62%, and 15.96% respectively [3]. - The current price-to-earnings ratios are projected at 51x, 42x, and 37x for the respective years [3]. - The investment rating remains "Buy" based on the solid growth prospects and product performance [3]. Analyst Ratings - In the last 90 days, two institutions have provided ratings for the stock, with one rating it as "Buy" and the other as "Overweight" [4].

东吴证券研报指出，金徽酒25H1归母净利润2.98亿元，同比+1.12%；其中25Q2归母净利润0.64亿元， 同比-12.78%。年份、柔和系列增势延续，持续深耕大西北根据地。分地区来看，上半年省内、省外营 收分别同比-1.11%、+1.78%，省内各个区域趋势不错，省外陕西经过两年调整目前势能向好，华东聚 焦核心区域有所调整。短期来看，当前白酒产业虽进入深度调整，但金徽品牌、渠道协同发力，销售节 奏彰显韧性。中长期来看，金徽经营风格稳健同时不失进取，坚持"布局全国、深耕西北、重点突破"战 略路径，稳步推进甘青新市场一体化和陕宁市场一体化建设，进一步夯实大西北根据地市场，着力培育 华东市场、北方市场为增长新引擎。二季度升级韧性延续，回款节奏稳健，中长期持续推进大西北根据 地市场一体化建设。维持"买入"评级。 ...